News

Revance Adds Life Sciences Audit Executive Chris Nolet to Board of Directors

MedEsthetics Iconic Brand Builder Joins Revance Board Of Directors

Shattering Age-Old Barriers

Revance Adds Iconic Brand Builder Jill Beraud to Board of Directors

Beauty Bytes with Dr. Kay Long Lasting Toxins, DAXI, & Success with Dan Browne, CEO of Revance

Dermatology Times Neurotoxin news: The DAXI differentiator

Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing

SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference

Revance Announces Ground-Breaking Data Presentations at Leading International Neurotoxin Conference

Revance Highlights Recent Regulatory Progress and Provides Anticipated 2019 Milestones

Revance’s RT002 Demonstrates Unprecedented Efficacy and Duration In Largest-Ever Aesthetic Neuromodulator Clinical Program

Revance Announces China Market License Agreement with Fosun Pharma for RT002

Latest News: